Lodo Therapeutics
New York, US · Founded 2015 · Delaware corporation · 2 known investors
Founders & leadership
DP
David PomplianoExecutive
DM
David McElligottExecutive
Board
DS
David SchubertBoard director
JM
Joel MarcusBoard director
LR
Lindsay RayleBoard director
BD
Barbara DaltonBoard director
SG
Steve GillisBoard director
MJ
M. Johnston ErwinBoard director
MU
TL
Thong LeBoard director
AX
Asish XavierBoard director
JS
James SullivanBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$19.9M disclosed across 1 round · 2015
▶$19.9MraisedJan 2017 · 13 investors · BiotechnologyRule 506(b)
▶$19.9MraisedJan 2017 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchubertExecutive Officer, Promoter
- Joel MarcusDirector
- Lindsay RayleExecutive Officer, Promoter
- Barbara DaltonDirector
- Steve GillisDirector
- David PomplianoExecutive Officer
- M. Johnston ErwinDirector
- Misti UshioDirector
- Thong LeExecutive Officer, Director, Promoter
- David McElligottExecutive Officer, Promoter
- Asish XavierDirector
- James SullivanDirector
- Offering amount
- $19.9M
- Amount sold
- $19.9M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Lodo Therapeutics's investors?
- Lodo Therapeutics's investors include Pfizer Venture Investments, Digitalis Ventures.
- How much funding has Lodo Therapeutics raised?
- Lodo Therapeutics has disclosed $19.9M raised across 1 round.
- Where is Lodo Therapeutics headquartered?
- Lodo Therapeutics is headquartered in New York, US.